Clinical Trial Update: Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2 [Phase 1]

View source ↗

Summary

Completion of a Phase 1 safety study evaluating an HSV-2 DNA vaccine for recurrent genital herpes caused by HSV-2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• HSV-2 DNA vaccine (Herpes simplex virus type 2 DNA vaccine)

Snippet

Sponsor: PowderMed | Conditions: HSV-2 | Phase 1 | Status: COMPLETED